Pharma | Stocks To Buy 2017

: Soared over 440% after announcing a gene therapy partnership with Pfizer .

: Held its position as the world's largest pharma company by market cap ($387B in 2017). ⚠️ Key Trends & Risks pharma stocks to buy 2017

: Maintained its lead in prescription sales and remained a "Strong Buy" due to its robust clinical pipeline and steady dividend. : Soared over 440% after announcing a gene

: Gained over 700% after positive Phase 2 data for its epilepsy treatment, ganaxolone. pharma stocks to buy 2017